Kiniksa Pharmaceuticals Ltd (KNSA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

CLARENDON HOUSE HAMILTON, BERMUDA HM11

Kiniksa Pharmaceuticals, Ltd. operates as a clinical-stage biopharmaceutical company. The Company focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals serves patients worldwide.

Data as of 2020-05-30
Market Cap1.223 Billion Shares Outstanding58.615 Million Avg 30-day Volume288.291 Thousand
P/E Ratio Dividend Yield EPS-2.22
Price/Sales Price cash flow ratio Price free cash flow ratio-9.5
Book Value3.51 Price to Tangible Book5.94 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low22.77 / 5.01 Stddev
View SEC Filings from KNSA instead.

View recent insider trading info

Funds Holding KNSA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KNSA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

49.9 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
  • 10% Owner
32,756,002 2020-05-26 2

BEETHAM THOMAS W. EVP & CHIEF LEGAL OFFICER

  • Officer
29,589 2020-04-20 4

LEVY RICHARD S

  • Director
0 2020-04-03 0

POPOVITS KIMBERLY J

  • Director
0 2020-03-26 0

PATEL SANJ K CHAIRMAN & CEO

  • Officer
  • Director
0 2020-03-13 4

PAOLINI JOHN F. SVP & CHIEF MEDICAL OFFICER

  • Officer
0 2020-03-13 7

RIZVI QASIM CHIEF COMMERCIAL OFFICER

  • Officer
0 2020-03-13 4

MEGNA MICHAEL R CHIEF ACCOUNTING OFFICER

  • Officer
0 2020-03-13 2

MCCAIN TRACEY L EVP AND CHIEF LEGAL OFFICER

  • Officer
21,683 2020-03-09 0

QUART BARRY D PRESIDENT & CEO

  • Officer
  • Director
88,068 2019-12-31 0

HEBERLIG CHRIS EVP & CFO

  • Officer
0 2019-09-17 1

MAHONEY STEPHEN F. PRESIDENT & COO

  • Officer
0 2019-09-17 1

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PARTNERS, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF A 10% GROUP
4,123,266 2019-06-27 0

MALLEY THOMAS

  • Director
0 2019-06-25 0

BOESS CARSTEN

0 2019-01-28 0

CORMORANT ASSET MANAGEMENT, LP

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
No longer subject to file 2018-10-31 0

CORMORANT ASSET MANAGEMENT, LP

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND I, LP

CHEN BIHUA

  • Director
  • 10% Owner
0 2018-10-30 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2018-07-23 0

BIGGAR STEPHEN R

  • Director
0 2018-05-23 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2020-05-18 A 1,465,603 $18.25 a 10,302,952 0.00 indirect

BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes

667, L.P. - Director - > 10% Owner see footnotes

BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes

BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes

BAKER FELIX - Director - > 10% Owner see footnotes

BAKER JULIAN - Director - > 10% Owner see footnotes

2020-05-18 A 134,397 $18.25 a 1,050,440 0.00 indirect

BEETHAM THOMAS W. - Officer EVP & CHIEF LEGAL OFFICER

2020-04-21 S 955 $20.44 d 29,589 29,589.00 direct yes

BEETHAM THOMAS W. - Officer EVP & CHIEF LEGAL OFFICER

2020-04-21 S 1,563 $19.56 d 30,544 29,589.00 direct yes

BEETHAM THOMAS W. - Officer EVP & CHIEF LEGAL OFFICER

2020-04-20 S 47,423 $19.06 d 32,107 29,589.00 direct yes

Elevate your investments